There could be a possible bear trap forming under the support at $1.20. There was a quick push below this level, but momentum was halted quickly and RAC has failed to move lower. If that is the case, we should look for a move back above $1.20 next week to confirm.
Assuming everything is going well with the first patient dosed, next week should align with the second Bis+Dox combo dose being administered, and hopefully confirmation that the first combo dose was safely tolerated. I know DT has said they will report on a cohort level, but first successful combo dosing may hopefully be considered important enough to warrant a separate announcement and if so could give us some news to help "spring" the (bear) trap.
RAC Price at posting:
$1.19 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)